Study on Effect of Intestinal Microbiota Transplantation in Hepatitis B Virus Induced Cirrhosis
A Randomised Study on Intestinal Microbiota Transplantation for Hepatitis B Virus Induced Cirrhosis
Sponsor: Zhongshan Hospital Xiamen University
Listed as NCT03437876, this NA trial focuses on Cirrhosis, Liver and remains ongoing. Sponsored by Zhongshan Hospital Xiamen University, it has been updated 5 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jun 2018 — Jan 2021 [monthly]
Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Recruiting NA
First recorded
Oct 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Zhongshan Hospital Xiamen University
For direct contact, visit the study record on ClinicalTrials.gov .